Global and Region Chronic Idiopathic Constipation Treatment Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Chronic Idiopathic Constipation Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Idiopathic Constipation Treatmentmarket, defines the market attractiveness level of Chronic Idiopathic Constipation Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chronic Idiopathic Constipation Treatment industry, describes the types of Chronic Idiopathic Constipation Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Idiopathic Constipation Treatment market and the development prospects and opportunities of Chronic Idiopathic Constipation Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Idiopathic Constipation Treatment market in Chapter 13.

    By Player:

    • Sucampo Pharmaceuticals Inc (Mallinckrodt)

    • Janssen Pharmaceuticals Inc (Johnson and Johnson)

    • Bayer AG

    • Albireo Pharma Inc

    • Takeda Pharmaceutical Company

    • SEBELA PHARMACEUTICALS

    • Bausch Health

    • Ironwood Pharmaceuticals Inc

    • Allergan

    • Sanofi

    By Type:

    • Blood Tests

    • Sigmoidoscopy

    • Colonoscopy

    • Balloon Expulsion Test

    • Anorectal Manometry

    • Colonic Transit Study

    • Defecography

    • Others

    By End-User:

    • Hospitals

    • Gastroenterology clinics

    • Diagnostic Centers

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chronic Idiopathic Constipation Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chronic Idiopathic Constipation Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chronic Idiopathic Constipation Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chronic Idiopathic Constipation Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chronic Idiopathic Constipation Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Chronic Idiopathic Constipation Treatment Consumption (2017-2022)

    • 7.2 United States Chronic Idiopathic Constipation Treatment Consumption (2017-2022)

    • 7.3 Europe Chronic Idiopathic Constipation Treatment Consumption (2017-2022)

    • 7.4 China Chronic Idiopathic Constipation Treatment Consumption (2017-2022)

    • 7.5 Japan Chronic Idiopathic Constipation Treatment Consumption (2017-2022)

    • 7.6 India Chronic Idiopathic Constipation Treatment Consumption (2017-2022)

    • 7.7 South Korea Chronic Idiopathic Constipation Treatment Consumption (2017-2022)

    8 Region and Country-wise Chronic Idiopathic Constipation Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Chronic Idiopathic Constipation Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Chronic Idiopathic Constipation Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Chronic Idiopathic Constipation Treatment Consumption Forecast (2022-2028)

    • 8.4 China Chronic Idiopathic Constipation Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Chronic Idiopathic Constipation Treatment Consumption Forecast (2022-2028)

    • 8.6 India Chronic Idiopathic Constipation Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Chronic Idiopathic Constipation Treatment Consumption Forecast (2022-2028)

    9 Global Chronic Idiopathic Constipation Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Chronic Idiopathic Constipation Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Blood Tests Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Sigmoidoscopy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Colonoscopy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Balloon Expulsion Test Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Anorectal Manometry Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Colonic Transit Study Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Defecography Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chronic Idiopathic Constipation Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Gastroenterology clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Chronic Idiopathic Constipation Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Chronic Idiopathic Constipation Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Blood Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Sigmoidoscopy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Colonoscopy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Balloon Expulsion Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Anorectal Manometry Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Colonic Transit Study Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Defecography Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chronic Idiopathic Constipation Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Gastroenterology clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chronic Idiopathic Constipation Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chronic Idiopathic Constipation Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chronic Idiopathic Constipation Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chronic Idiopathic Constipation Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chronic Idiopathic Constipation Treatment Market Competitive Analysis

    • 14.1 Sucampo Pharmaceuticals Inc (Mallinckrodt)

      • 14.1.1 Sucampo Pharmaceuticals Inc (Mallinckrodt) Company Details

      • 14.1.2 Sucampo Pharmaceuticals Inc (Mallinckrodt) Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sucampo Pharmaceuticals Inc (Mallinckrodt) Chronic Idiopathic Constipation Treatment Product and Service

    • 14.2 Janssen Pharmaceuticals Inc (Johnson and Johnson)

      • 14.2.1 Janssen Pharmaceuticals Inc (Johnson and Johnson) Company Details

      • 14.2.2 Janssen Pharmaceuticals Inc (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Janssen Pharmaceuticals Inc (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Product and Service

    • 14.3 Bayer AG

      • 14.3.1 Bayer AG Company Details

      • 14.3.2 Bayer AG Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer AG Chronic Idiopathic Constipation Treatment Product and Service

    • 14.4 Albireo Pharma Inc

      • 14.4.1 Albireo Pharma Inc Company Details

      • 14.4.2 Albireo Pharma Inc Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Albireo Pharma Inc Chronic Idiopathic Constipation Treatment Product and Service

    • 14.5 Takeda Pharmaceutical Company

      • 14.5.1 Takeda Pharmaceutical Company Company Details

      • 14.5.2 Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Product and Service

    • 14.6 SEBELA PHARMACEUTICALS

      • 14.6.1 SEBELA PHARMACEUTICALS Company Details

      • 14.6.2 SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Product and Service

    • 14.7 Bausch Health

      • 14.7.1 Bausch Health Company Details

      • 14.7.2 Bausch Health Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bausch Health Chronic Idiopathic Constipation Treatment Product and Service

    • 14.8 Ironwood Pharmaceuticals Inc

      • 14.8.1 Ironwood Pharmaceuticals Inc Company Details

      • 14.8.2 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Treatment Product and Service

    • 14.9 Allergan

      • 14.9.1 Allergan Company Details

      • 14.9.2 Allergan Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Allergan Chronic Idiopathic Constipation Treatment Product and Service

    • 14.10 Sanofi

      • 14.10.1 Sanofi Company Details

      • 14.10.2 Sanofi Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sanofi Chronic Idiopathic Constipation Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chronic Idiopathic Constipation Treatment

    • Figure Chronic Idiopathic Constipation Treatment Picture

    • Table Global Chronic Idiopathic Constipation Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Idiopathic Constipation Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Idiopathic Constipation Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chronic Idiopathic Constipation Treatment Consumption by Country (2017-2022)

    • Figure United States Chronic Idiopathic Constipation Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Chronic Idiopathic Constipation Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Chronic Idiopathic Constipation Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Chronic Idiopathic Constipation Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Chronic Idiopathic Constipation Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chronic Idiopathic Constipation Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Idiopathic Constipation Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Chronic Idiopathic Constipation Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chronic Idiopathic Constipation Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chronic Idiopathic Constipation Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chronic Idiopathic Constipation Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chronic Idiopathic Constipation Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chronic Idiopathic Constipation Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Tests Consumption and Growth Rate (2017-2022)

    • Figure Global Sigmoidoscopy Consumption and Growth Rate (2017-2022)

    • Figure Global Colonoscopy Consumption and Growth Rate (2017-2022)

    • Figure Global Balloon Expulsion Test Consumption and Growth Rate (2017-2022)

    • Figure Global Anorectal Manometry Consumption and Growth Rate (2017-2022)

    • Figure Global Colonic Transit Study Consumption and Growth Rate (2017-2022)

    • Figure Global Defecography Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Gastroenterology clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sigmoidoscopy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colonoscopy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Balloon Expulsion Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anorectal Manometry Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colonic Transit Study Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Defecography Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastroenterology clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chronic Idiopathic Constipation Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chronic Idiopathic Constipation Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Sucampo Pharmaceuticals Inc (Mallinckrodt) (Foundation Year, Company Profile and etc.)

    • Table Sucampo Pharmaceuticals Inc (Mallinckrodt) Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sucampo Pharmaceuticals Inc (Mallinckrodt) Chronic Idiopathic Constipation Treatment Product and Service

    • Table Janssen Pharmaceuticals Inc (Johnson and Johnson) (Foundation Year, Company Profile and etc.)

    • Table Janssen Pharmaceuticals Inc (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals Inc (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Chronic Idiopathic Constipation Treatment Product and Service

    • Table Albireo Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Albireo Pharma Inc Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Albireo Pharma Inc Chronic Idiopathic Constipation Treatment Product and Service

    • Table Takeda Pharmaceutical Company (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Product and Service

    • Table SEBELA PHARMACEUTICALS (Foundation Year, Company Profile and etc.)

    • Table SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Product and Service

    • Table Bausch Health (Foundation Year, Company Profile and etc.)

    • Table Bausch Health Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch Health Chronic Idiopathic Constipation Treatment Product and Service

    • Table Ironwood Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Treatment Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Chronic Idiopathic Constipation Treatment Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Chronic Idiopathic Constipation Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Chronic Idiopathic Constipation Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.